Abstract
Background
Cuproptosis is a novel form of cell death that is highly related to mitochondrial metabolism and mediated by protein lipoacetylation. This study systematically assessed the differential expression and genetic alterations of cuproptosis-related genes (CRGs) in head and neck squamous-cell carcinoma (HNSCC) and constructed CRG risk models to predict survival in patients with HNSCC.
Methods
We investigated the expression of 19 CRGs in HNSCC and noncancerous tissues, and the relationship between mutation load, immune infiltration, and clinical features was examined based on data from public databases. CRG risk models were constructed by univariate Cox analysis and lasso regression and validated by independent datasets for their accuracy in predicting survival outcomes in patients with HNSCC. The expression distribution of CRGs in HNSCC cells was further explored in the HNSCC single-cell sequencing dataset.
Results
NFE2L2, ATP7A, FDX1, LIAS, DLD, DLAT, PDHB, MTF1 and DBT were highly expressed in noncancerous samples, while GLS, CDKN2A and DLST were highly expressed in HNSCC samples (p < 0.05). Gene copy number variation frequency (CNV) revealed CDKN2A, FDX1 and DLAT copy number deletions and LIPT2 and NFE2L2 copy number increases. Ten CRGs were used to construct a risk model to predict overall survival (OS) in HNSCC, yielding reduced OS in the high-risk group compared to the low-risk group, training group (p = 9.733e − 05), and testing group (p = 0.040). The CRG risk model was significantly correlated with various immune cells, regulatory T cells (Tregs) and memory B cells were significantly negatively correlated (p = 0.027, p = 0.00084), and resting CD4 memory T cells was significantly positively correlated (p = 9e − 04). Most CRGs significantly affected the clinical characteristics of HNSCC. NFE2L2, SLC31A1, PDHA1, CDKN2A and DBT were highly expressed in epithelial cells of HNSCC, while SLC31A1, DBT and NFE2L2 were highly expressed in T cells, and SLC31A1 in B cells. In monocytes, NFE2L2, SLC31A1 and PDHA1 were highly expressed.
Conclusion
The CRG risk model can be used as a potential prognostic factor for HNSCC patients and may provide new insights into cancer treatment from the perspective of copper metabolism.
Similar content being viewed by others
Data availability
Publicly available datasets were analyzed in this study. This data can be found here: [https://portal.gdc.cancer.gov/], [https://www.ncbi.nlm.nih.gov/geo/]. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
References
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25–29
Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J et al (2020) Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun 11(1):3701 (PubMed PMID: 32709883. Pubmed Central PMCID: PMC7381612. Epub 2020/07/28)
Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R (2017) Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Element Res 175(1):57–64 (PubMed PMID: 27263537. Epub 2016/06/07)
Bao ZS, Zhang CB, Wang HJ, Yan W, Liu YW, Li MY et al (2013) Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme. CNS Neurosci Therap 19(9):714–720 (PubMed PMID: 23663361. Pubmed Central PMCID: PMC6493663. Epub 2013/05/15)
Blockhuys S, Celauro E, Hildesjö C, Feizi A, Stål O, Fierro-González JC et al (2017) Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics Integr Biomet Sci. 9(2):112–123 (PubMed PMID: 27942658. Epub 2016/12/13)
Brady DC, Crowe MS, Greenberg DN, Counter CM (2017) Copper chelation inhibits BRAF(V600E)-driven melanomagenesis and counters resistance to BRAF(V600E) and MEK1/2 inhibitors. Cancer Res 77(22):6240–6252 (PubMed PMID: 28986383. Pubmed Central PMCID: PMC5690876. Epub 2017/10/08)
Callejón-Leblic B, Gómez-Ariza JL, Pereira-Vega A, García-Barrera T (2018) Metal dyshomeostasis based biomarkers of lung cancer using human biofluids. Metallomics Integr Biomet Sci 10(10):1444–1451
Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576–582 (Pubmed Central PMCID: PMC4311405. Epub 2015/01/30)
Chen D, Cui QC, Yang H, Dou QP (2006) Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66(21):10425–10433 (PubMed PMID: 17079463. Epub 2006/11/03)
Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN et al (2018) CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma. Front Oncol 8:95
Chen F, Wang J, Chen J, Yan L, Hu Z, Wu J et al (2019) Serum copper and zinc levels and the risk of oral cancer: a new insight based on large-scale case–control study. Oral Dis 25(1):80–86 (PubMed PMID: 30107072. Epub 2018/08/15)
Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280–296 (PubMed PMID: 33514910. Epub 2021/01/31)
Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31(3):213–219 (PubMed PMID: 23396013. Pubmed Central PMCID: PMC3833702. Epub 2013/02/12)
Dang CV (2010) Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle (georgetown, TX) 9(19):3884–3886 (PubMed PMID: 20948290. Epub 2010/10/16)
Dang CV (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70(3):859–862 (PubMed PMID: 20086171. Pubmed Central PMCID: PMC2818441. Epub 2010/01/21)
Davis CI, Gu X, Kiefer RM, Ralle M, Gade TP, Brady DC (2020) Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation. Metallomics Integr Biomet Sci 12(12):1995–2008 (PubMed PMID: 33146201. Pubmed Central PMCID: PMC8315290. Epub 2020/11/05)
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953 (PubMed PMID: 30350310. Epub 2018/10/24)
Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM et al (2022) Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer 22(2):102–113 (PubMed PMID: 34764459. Pubmed Central PMCID: PMC8810673. Epub 2021/11/13)
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 38(6):675–678 (PubMed PMID: 32444850. Pubmed Central PMCID: PMC7386072. Epub 2020/05/24)
Grubman A, White AR (2014) Copper as a key regulator of cell signalling pathways. Expert Rev Mol Med 16:e11 (PubMed PMID: 24849048. Epub 2014/05/23)
Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61(1):92–105 (PubMed PMID: 15737082. Epub 2005/03/02)
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6(1):92 (PubMed PMID: 33243986. Pubmed Central PMCID: PMC7944998. Epub 2020/11/28)
Kahlson MA, Dixon SJ (2022) Copper-induced cell death. Science (new York, NY). 375(6586):1231–1232 (PubMed PMID: 35298241. Epub 2022/03/18)
Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of genes and genomes. Nucl Acids Res 28(1):27–30 (PubMed PMID: 10592173. Pubmed Central PMCID: PMC102409. Epub 1999/12/11)
Kenneth NS, Hucks GE Jr, Kocab AJ, McCollom AL, Duckett CS (2014) Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways. Cell Cycle (georgetown, TX) 13(6):1006–1014 (PubMed PMID: 24552822. Pubmed Central PMCID: PMC3984299. Epub 2014/02/21)
Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22 (PubMed PMID: 21160525. Epub 2010/12/17)
Li SR, Bu LL, Cai L (2022) Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther 7(1):158. PubMed PMID: 35562341. Pubmed Central PMCID: PMC9106713 member of Signal Transduction and Targeted Therapy, but she has not been involved in the process of the manuscript handling. Epub 2022/05/14
Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756 (PubMed PMID: 30341162. Pubmed Central PMCID: PMC6211645. Epub 2018/10/21)
Moreno-Betancur M, Sadaoui H, Piffaretti C, Rey G (2017) Survival analysis with multiple causes of death: extending the competing risks model. Epidemiology (cambridge, MA) 28(1):12–19 (PubMed PMID: 27362647. Epub 2016/07/01)
Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S et al (2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171(7):1611-1624 e24 (PubMed PMID: 29198524. Pubmed Central PMCID: PMC5878932. Epub 2017/12/05)
Rothenberg SM, Ellisen LW (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Investig 122(6):1951–1957 (Pubmed Central PMCID: PMC3589176. Epub 2012/07/27)
Tang D, Chen X, Kroemer G (2022) Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res 32(5):417–418 (PubMed PMID: 35354936. Pubmed Central PMCID: PMC9061796. Epub 2022/04/01)
Tomczak K, Czerwinska P, Wiznerowicz M (2015) The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (poznan, Poland) 19(1A):A68–A77 (Pubmed Central PMCID: PMC4322527. Epub 2015/02/19)
Tripathi P, Kamarajan P, Somashekar BS, MacKinnon N, Chinnaiyan AM, Kapila YL et al (2012) Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol 44(11):1852–1861 (PubMed PMID: 22743333. Pubmed Central PMCID: PMC3455146. Epub 2012/06/30)
Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science (new York, NY) 375(6586):1254–1261 (PubMed PMID: 35298263. Epub 2022/03/18)
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015) Proteomics. Tissue-based map of the human proteome. Science (new York, NY). 347(6220):1260419 (PubMed PMID: 25613900. Epub 2015/01/24)
Wichmann G, Rosolowski M, Krohn K, Kreuz M, Boehm A, Reiche A et al (2015) The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer 137(12):2846–2857 (PubMed PMID: 26095926. Epub 2015/06/23)
Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612 (PubMed PMID: 24113773. Pubmed Central PMCID: PMC3826632. Epub 2013/10/12)
Zhang X, Yang Q (2018) Association between serum copper levels and lung cancer risk: a meta-analysis. J Int Med Res 46(12):4863–4873 (PubMed PMID: 30296873. Pubmed Central PMCID: PMC6300955. Epub 2018/10/10)
Zhang CB, Zhu P, Yang P, Cai JQ, Wang ZL, Li QB et al (2015) Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling. Oncotarget 6(34):36643–36651 (PubMed PMID: 26436699. Pubmed Central PMCID: PMC4742201. Epub 2015/10/06)
Zhao KL, Yang XJ, Jin HZ, Zhao L, Hu JL, Qin WJ (2019) Double-edge role of B cells in tumor immunity: potential molecular mechanism. Curr Med Sci 39(5):685–689 (PubMed PMID: 31612383. Epub 2019/10/16)
Acknowledgements
We thank the study participants and research staff for their contributions and commitment to this study. The first author would like to thank Dr. Wei Xia, Department of the First Affiliated Hospital of Guangxi Medical University, for his support and careful supervision of this study, which provided inspiration and added details for this study and Dr. Feng Qingyuan, Department of Otorhinolaryngology, Renmin Hospital of Wuhan University for her encouragement, patient companionship and health care during the study period.
Funding
This work was supported by the Chongqing Municipal Health and Wellness Commission, Clinical and experimental study of terahertz time-domain system in judging pathological margin of hypopharyngeal carcinoma, [2021MSXM018]. A grant from the Chongqing Medical University Postgraduate Research Innovation Project, Clinical and experimental study of terahertz time-domain system in the determination of pathological margin of laryngeal carcinoma, [CYS21253].
Author information
Authors and Affiliations
Contributions
XJ, JK, LJ, XA, HM and ZL conducted data analysis and verification. XJ and WY conceived the study. XJ and JK drafted the manuscript. XJ, JK, LJ, XA, HM and ZL collected the data. WY and ZL commented on previous versions of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethics approval and consent to participate
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, X., Ke, J., Jia, L. et al. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. J Cancer Res Clin Oncol 149, 203–218 (2023). https://doi.org/10.1007/s00432-022-04471-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-022-04471-7